[Alnylam Pharmaceuticals](https://www.alnylam.com/about-alnylam)

May 29, 2026 (full proposal, RFP ALNY-RFP-TTR-13)

Up to $250,000 per proposal; multiple proposals may be funded; duration and total funds vary by project.

Supports independent educational initiatives advancing clinical decision-making in transthyretin-mediated amyloidosis (ATTR-CM).

Only organizations (not individuals) may apply; ACCME accreditation required for medical education providers.

--- ## Description Alnylam Pharmaceuticals’ Grants and Giving Office is soliciting proposals for independent educational activities that address gaps in the screening, diagnosis, monitoring, and management of transthyretin-mediated amyloidosis (ATTR-CM). This RFP (ALNY-RFP-TTR-13) seeks to fund initiatives that equip clinicians with actionable, evidence-based tools and frameworks for real-world clinical decision-making, with a focus on practical application across the patient journey. Eligible activities include CME-accredited programs, symposia, digital platforms, and live or virtual educational events. The intent is to improve patient outcomes by enhancing healthcare professionals' knowledge and implementation of best practices in ATTR-CM. --- ## Due Dates - May 29, 2026: Submission deadline for full proposals (RFP ALNY-RFP-TTR-13) --- ## Funding Amount - Individual proposals may request up to $250,000 USD. - Multiple proposals may be selected for funding; applicants may submit for different venues or channels. - The amount awarded may be less than requested, and applicants are encouraged to seek additional funding sources. - Grant funds may not be used for meals for attendee HCPs. --- ## Eligibility - **Eligible applicants:** Professional associations, patient advocacy organizations, healthcare institutions, medical education companies, and other organizations focused on healthcare improvement. - **Ineligible applicants:** Individuals, healthcare provider practice groups, provider-owned clinics, managed care organizations, and pharmacy benefit managers. - **ACCME accreditation:** Required for medical education providers; the applicant must be the accredited provider. - **Geographic scope:** U.S. and/or global. - **Target audience:** Specialists managing ATTR-CM (e.g., cardiologists, cardiac imaging specialists, clinical pharmacists). --- ## Application Process - Submit proposals electronically via the [Alnylam Grants Portal](https://alnylam-grants.steeprockinc.com) in English. - Proposals must include: - Comprehensive gap analysis/needs assessment - Detailed educational design, learning objectives, and content outline - Budget breakdown and justification - Accreditation documentation (if applicable) - Methods for evaluation, dissemination, and sustainability - Disclosure and conflict of interest policies - Project timeline - Proposals should be tailored to the intended venue/channel and audience. - All submissions must be received by May 29, 2026. - Notification of decisions will be sent by June 12, 2026. - For questions, contact [grants@alnylam.com](mailto:grants@alnylam.com). --- ## Additional Information - Activities must be compliant with all applicable legal and regulatory requirements. - Transparency in Alnylam’s support is required; no tangible business benefit to Alnylam. - Proposals can be for symposia at major cardiology congresses, digital CME platforms, or regional/national educational events. - Preference is given to programs offering enduring, accessible educational materials for healthcare professionals. - All approved requests require execution of a formal grant agreement. --- ## External Links - [Alnylam Grants and Giving Program Overview](https://www.alnylam.com/about-alnylam/grants-and-giving) - [Full RFP Document (PDF)](https://www.alnylam.com/sites/default/files/pdfs/ALNY-RFP-TTR-13%20Advancing%20Clinical%20Decision-Making%20in%20ATTR-CM.pdf) - [Alnylam Grants Portal (Submission)](https://alnylam-grants.steeprockinc.com) - [Alnylam Investigator-Initiated Studies](https://www.alnylam.com/about-alnylam/investigator-initiated-studies/) --- ## Contact Information | Purpose | Contact | |------------------------|---------------------------------------------------------| | General Inquiries | [grants@alnylam.com](mailto:grants@alnylam.com) | | Grants Portal | [Alnylam Grants Portal](https://alnylam-grants.steeprockinc.com) | | Funder Homepage | [Alnylam Pharmaceuticals](https://www.alnylam.com/about-alnylam) |

Grants and Giving

Sign in to see full grant listing